Evidence map›Paper›PMID 38205958›Full record

ArticleMicrobiology spectrum2024

Molecular characteristics, fitness, and virulence of high-risk and non-high-risk clones of carbapenemase-producing

Anni-Maria Örmälä-Tiznado, Lisa Allander, Makaoui Maatallah, Muhammad Humaun Kabir, Sylvain Brisse, Linus Sandegren, Sheetal Patpatia, Maarten Coorens, Christian G Giske

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Clonal Dissemination of Pandrug-ResistantInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anni-Maria Örmälä-TiznadoDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0006-1219-9354
Lisa AllanderDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Makaoui MaatallahLaboratoire d'Analyse, Traitement et Valorisation des Polluants de l'Environnement et des Produits (LATVPEP: LR01ES16), Faculté de Pharmacie de Monastir, Université de Monastir, Monastir, Tunisia.
Muhammad Humaun KabirDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Sylvain BrisseBiodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur, Paris, France.ORCID 0000-0002-2516-2108
Linus SandegrenDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-7382-9782
Sheetal PatpatiaDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Maarten CoorensDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Christian G GiskeDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Funding

Vetenskapsrådet (VR) 2016-02889
6 · The paper itself

Abstract

Extensively drug-resistant (XDR)

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesClone CellsLarvaMicrobial Sensitivity TestsVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseVirulence Factorsantimicrobial resistancecompetitionfitnessflow cytometryGalleria mellonellaKlebsiella pneumoniaevirulence

Identifiers

PMID38205958
PMCPMC10845972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.